293 related articles for article (PubMed ID: 34413141)
1.
Mathey C; Keyzer C; Blocklet D; Van Simaeys G; Trotta N; Lacroix S; Corvilain B; Goldman S; Moreno-Reyes R
J Nucl Med; 2022 May; 63(5):785-791. PubMed ID: 34413141
[TBL] [Abstract][Full Text] [Related]
2.
Beheshti M; Hehenwarter L; Paymani Z; Rendl G; Imamovic L; Rettenbacher R; Tsybrovskyy O; Langsteger W; Pirich C
Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1762-1771. PubMed ID: 29516131
[TBL] [Abstract][Full Text] [Related]
3. Is 18F-fluorocholine-positron emission tomography/computerized tomography a new imaging tool for detecting hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism?
Michaud L; Burgess A; Huchet V; Lefèvre M; Tassart M; Ohnona J; Kerrou K; Balogova S; Talbot JN; Périé S
J Clin Endocrinol Metab; 2014 Dec; 99(12):4531-6. PubMed ID: 25215560
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Performance of Cervical Ultrasound,
Boudousq V; Guignard N; Gilly O; Chambert B; Mamou A; Moranne O; Zemmour M; Sharara H; Lallemant B
J Nucl Med; 2022 Jul; 63(7):1081-1086. PubMed ID: 34857659
[TBL] [Abstract][Full Text] [Related]
5. 18F-fluorocholine PET/CT and conventional imaging in primary hyperparathyroidism.
Dudoignon D; Delbot T; Cottereau AS; Dechmi A; Bienvenu M; Koumakis E; Cormier C; Gaujoux S; Groussin L; Cochand-Priollet B; Clerc J; Wartski M
Diagn Interv Imaging; 2022 May; 103(5):258-265. PubMed ID: 35039246
[TBL] [Abstract][Full Text] [Related]
6. 18F-fluorocholine PET/CT detects parathyroid gland hyperplasia as well as adenoma: 401 PET/CTs in one center.
Talbot JN; Périé S; Tassart M; Delbot T; Aveline C; Zhang-Yin J; Kerrou K; Gaujoux S; Wagner I; Bennis M; Ménégaux F; Breton S; Cochand-Priollet B; Christin-Maitre S; Groussin L; Haymann JP; Baujat B; Balogova S; Montravers F
Q J Nucl Med Mol Imaging; 2023 Jun; 67(2):96-113. PubMed ID: 36995286
[TBL] [Abstract][Full Text] [Related]
7. Performance of F-18 Fluorocholine PET/CT for Detection of Hyperfunctioning Parathyroid Tissue in Patients with Elevated Parathyroid Hormone Levels and Negative or Discrepant Results in conventional Imaging.
Uslu-Beşli L; Sonmezoglu K; Teksoz S; Akgun E; Karayel E; Pehlivanoglu H; Khosroshahi BR; Ocak M; Kabasakal L; Sager S; Bukey Y
Korean J Radiol; 2020 Feb; 21(2):236-247. PubMed ID: 31997599
[TBL] [Abstract][Full Text] [Related]
8. Challenging pre-surgical localization of hyperfunctioning parathyroid glands in primary hyperparathyroidism: the added value of
Grimaldi S; Young J; Kamenicky P; Hartl D; Terroir M; Leboulleux S; Berdelou A; Hadoux J; Hescot S; Remy H; Baudin E; Schlumberger M; Deandreis D
Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1772-1780. PubMed ID: 29680989
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of fluorine-18-choline PET/CT in comparison with 99mTc-MIBI SPECT/CT in the localization of a hyperfunctioning parathyroid gland in primary hyperparathyroidism.
Araz M; Soydal Ç; Özkan E; Kir MK; İbiş E; Güllü S; Erdoğan MF; Emral R; Küçük ÖN
Nucl Med Commun; 2018 Nov; 39(11):989-994. PubMed ID: 30138157
[TBL] [Abstract][Full Text] [Related]
10. A Pilot Comparison of 18F-fluorocholine PET/CT, Ultrasonography and 123I/99mTc-sestaMIBI Dual-Phase Dual-Isotope Scintigraphy in the Preoperative Localization of Hyperfunctioning Parathyroid Glands in Primary or Secondary Hyperparathyroidism: Influence of Thyroid Anomalies.
Michaud L; Balogova S; Burgess A; Ohnona J; Huchet V; Kerrou K; Lefèvre M; Tassart M; Montravers F; Périé S; Talbot JN
Medicine (Baltimore); 2015 Oct; 94(41):e1701. PubMed ID: 26469908
[TBL] [Abstract][Full Text] [Related]
11. The utility of 18F-fluorocholine PET/CT in the imaging of parathyroid adenomas.
Mazurek A; Dziuk M; Witkowska-Patena E; Chudzinski W; Piszczek S; Gizewska A; Saracyn M
Endokrynol Pol; 2022; 73(1):43-48. PubMed ID: 35119087
[TBL] [Abstract][Full Text] [Related]
12.
Gass JM; Wicke C; Mona C; Strobel K; Müller W; Metzger J; Suter-Widmer I; Henzen C; Fischli S
Endocrine; 2022 Feb; 75(2):593-600. PubMed ID: 34561784
[TBL] [Abstract][Full Text] [Related]
13. Multiple endocrine neoplasia type 1 or 4: detection of hyperfunctioning parathyroid glands with 18F-fluorocholine PET/CT. Illustrative cases and pitfalls.
Talbot JN; Zhang-Yin J; Kerrou K; Aveline C; Vagne B; Bélissant O; Tassart M; Périé S; Bouchard P; Christin-Maitre S; Ménégaux F; Groussin L; Gaujoux S; Balogová S; Montravers F
Q J Nucl Med Mol Imaging; 2022 Jun; 66(2):130-140. PubMed ID: 35005879
[No Abstract] [Full Text] [Related]
14. Comparative Effectiveness of Ultrasonography, 99mTc-Sestamibi, and 18F-Fluorocholine PET/CT in Detecting Parathyroid Adenomas in Patients With Primary Hyperparathyroidism.
Thanseer N; Bhadada SK; Sood A; Mittal BR; Behera A; Gorla AKR; Kalathoorakathu RR; Singh P; Dahiya D; Saikia UN; Rao SD
Clin Nucl Med; 2017 Dec; 42(12):e491-e497. PubMed ID: 28902729
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid imaging by (18)F-fluorocholine PET/CT in patients with primary hyperparathyroidism and inconclusive conventional methods: clinico-pathological correlations.
Zajíčková K; Zogala D; Kubinyi J
Physiol Res; 2018 Nov; 67(Suppl 3):S551-S557. PubMed ID: 30484682
[TBL] [Abstract][Full Text] [Related]
16. 18F-fluorocholine PET/MRI versus ultrasound and sestamibi for the localization of parathyroid adenomas.
Noltes ME; Rotstein L; Eskander A; Kluijfhout WP; Bongers P; Brouwers AH; Kruijff S; Metser U; Pasternak JD; Veit-Haibach P
Langenbecks Arch Surg; 2023 Apr; 408(1):155. PubMed ID: 37079138
[TBL] [Abstract][Full Text] [Related]
17. 18F-Fluorocholine PET/CT and Parathyroid 4D Computed Tomography for Primary Hyperparathyroidism: The Challenge of Reoperative Patients.
Amadou C; Bera G; Ezziane M; Chami L; Delbot T; Rouxel A; Leban M; Herve G; Menegaux F; Leenhardt L; Kas A; Trésallet C; Ghander C; Lussey-Lepoutre C
World J Surg; 2019 May; 43(5):1232-1242. PubMed ID: 30659347
[TBL] [Abstract][Full Text] [Related]
18.
Cuderman A; Senica K; Rep S; Hocevar M; Kocjan T; Sever MJ; Zaletel K; Lezaic L
J Nucl Med; 2020 Apr; 61(4):577-583. PubMed ID: 31562221
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Performance of 99mTc-Sestamibi SPECT/CT and 18F-Choline PET/CT in Locating Hyperfunctioning Parathyroid Glands in Patients with Primary Hyperparathyroidism.
Mandic A; Kraljevic I; Skoric Polovina T; Zibar Tomsic K; Dusek T; Balasko A; Solak M; Kastelan D
Exp Clin Endocrinol Diabetes; 2024 Apr; 132(4):216-220. PubMed ID: 38320618
[TBL] [Abstract][Full Text] [Related]
20. Upfront F18-choline PET/CT versus Tc99m-sestaMIBI SPECT/CT guided surgery in primary hyperparathyroidism: the randomized phase III diagnostic trial APACH2.
Quak E; Lasne Cardon A; Ciappuccini R; Lasnon C; Bastit V; Le Henaff V; Lireux B; Foucras G; Jaudet C; Berchi C; Grellard JM; Lequesne J; Clarisse B; Bardet S
BMC Endocr Disord; 2021 Jan; 21(1):3. PubMed ID: 33413316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]